News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Harvard University Researchers Show Specially Formulated High EPA Omega-3 Supplement Effective as a Stand-Alone Treatment for Children with Bipolar Disorder, ADD


4/4/2007 12:48:45 PM

BOSTON--(BUSINESS WIRE)--A recently published study by researchers at Harvard’s Massachusetts General Hospital shows that a specially formulated high EPA Omega-3 fatty acid supplement should be the first-line treatment for children with ADD, ADHD, bipolar disorder, and other educational and behavioral problems. The OmegaBrite™ supplement of Omega-3 fatty acids was tested for effectiveness and safety on 20 boys and girls with bipolar disorder, 6 to 17 years old, over an eight-week period. Half of these participants experienced a rapid 30 percent reduction in symptoms with no side effects.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES